[Adverse effects of new oncologic therapies]
- PMID: 21792802
- DOI: 10.1024/1661-8157/a000609
[Adverse effects of new oncologic therapies]
Similar articles
-
[Interdisciplinary recommendations for the treatment of metastatic renal cell carcinoma].Aktuelle Urol. 2010 May;41(3):193-6. doi: 10.1055/s-0030-1247395. Epub 2010 May 18. Aktuelle Urol. 2010. PMID: 20486036 German.
-
[Targeted therapies and their indications in solid neoplasias].Rev Med Interne. 2009 May;30(5):416-24. doi: 10.1016/j.revmed.2008.12.022. Epub 2009 Mar 18. Rev Med Interne. 2009. PMID: 19299048 Review. French.
-
Update on systemic therapies of metastatic renal cell carcinoma.World J Urol. 2010 Jun;28(3):303-9. doi: 10.1007/s00345-010-0519-5. Epub 2010 Feb 24. World J Urol. 2010. PMID: 20180125 Review.
-
Treatment of patients with advanced neurofibromatosis type 2 with novel molecularly targeted therapies: from bench to bedside.J Clin Oncol. 2012 Feb 10;30(5):e64-8. doi: 10.1200/JCO.2011.38.2614. Epub 2011 Dec 27. J Clin Oncol. 2012. PMID: 22203760 Free PMC article. Clinical Trial. No abstract available.
-
[Oncology 2008].Dtsch Med Wochenschr. 2008 Jun;133(25-26):1395-9. doi: 10.1055/s-2008-1081075. Epub 2008 Jun 3. Dtsch Med Wochenschr. 2008. PMID: 18521794 Review. German. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous